Clearpoint Neuro Inc
CLPT15.810USD
-2.420-13.27%
收盘 11/07, 16:00（美东）报价延迟15分钟
449.45M总市值
亏损市盈率 TTM
关于 Clearpoint Neuro Inc 公司
ClearPoint Neuro, Inc. 是一家全球设备、细胞和基因治疗公司，为大脑和脊柱提供精确导航。该公司提供临床产品以及受控药物和设备输送的临床前开发服务。该公司的旗舰产品是 ClearPoint Neuro 导航系统。其首款产品 ClearPoint 系统是一个由资本设备和一次性产品组成的集成系统，旨在允许在磁共振成像 (MRI) 套件中对大脑进行微创手术。ClearPoint Array Neuro 导航系统及其主要一次性组件旨在部署在手术室环境中，同时也可用于 MRI 套件。它与北美、欧洲、亚洲和南美的医疗保健和研究中心合作。它还为全球临床前研究和临床试验中直接向中枢神经系统输送治疗剂提供解决方案。
Clearpoint Neuro Inc简介
公司代码CLPT
公司名称Clearpoint Neuro Inc
上市日期Jul 03, 2019
CEOMr. Joseph Michael Burnett
员工数量115
证券类型Ordinary Share
年结日Jul 03
公司地址120 S. Sierra Avenue
城市SOLANA BEACH
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92075
电话19499006833
网址https://www.clearpointneuro.com/
公司代码CLPT
上市日期Jul 03, 2019
CEOMr. Joseph Michael Burnett
Clearpoint Neuro Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.87K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.08K
-14.51%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mr. Jeremy L. Stigall
Mr. Jeremy L. Stigall
Chief Business Officer
Chief Business Officer
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.87K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.08K
-14.51%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Products: Functional neurosurgery
3.43M
37.24%
Services: Biologics and drug delivery
2.87M
31.12%
Products: Biologics and drug delivery
1.87M
20.30%
Product Systems and software products
694.00K
7.53%
Services: Capital equipment and other
350.00K
3.80%
地区USD
名称
营收
占比
United States
9.21M
100.00%
业务
地区
业务USD
名称
营收
占比
Products: Functional neurosurgery
3.43M
37.24%
Services: Biologics and drug delivery
2.87M
31.12%
Products: Biologics and drug delivery
1.87M
20.30%
Product Systems and software products
694.00K
7.53%
Services: Capital equipment and other
350.00K
3.80%
股东统计
更新时间: 10月22日 周三
更新时间: 10月22日 周三
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.28%
The Vanguard Group, Inc.
5.27%
Bigger Capital Funds, LP
4.10%
PTC Therapeutics Inc
3.15%
Geode Capital Management, L.L.C.
2.20%
其他
80.01%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.28%
The Vanguard Group, Inc.
5.27%
Bigger Capital Funds, LP
4.10%
PTC Therapeutics Inc
3.15%
Geode Capital Management, L.L.C.
2.20%
其他
80.01%
股东类型
持股股东
占比
Investment Advisor
19.70%
Investment Advisor/Hedge Fund
8.74%
Hedge Fund
7.68%
Individual Investor
5.21%
Corporation
3.15%
Research Firm
2.54%
Venture Capital
0.10%
Bank and Trust
0.09%
Pension Fund
0.08%
其他
52.71%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
230
11.01M
38.73%
+8.63K
2025Q2
225
12.82M
45.36%
+349.96K
2025Q1
230
12.08M
42.76%
-158.33K
2024Q4
216
11.35M
41.09%
+117.64K
2024Q3
204
10.32M
38.18%
-558.62K
2024Q2
199
10.56M
39.44%
-945.58K
2024Q1
197
10.90M
40.86%
+64.32K
2023Q4
197
9.84M
39.93%
-1.22M
2023Q3
198
9.05M
36.76%
-2.10M
2023Q2
200
8.72M
35.43%
-782.48K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.50M
5.27%
+1.13M
+307.45%
Jun 30, 2025
The Vanguard Group, Inc.
1.48M
5.19%
+191.14K
+14.89%
Jun 30, 2025
Bigger Capital Funds, LP
1.17M
4.1%
+31.67K
+2.79%
Jun 30, 2025
PTC Therapeutics Inc
894.58K
3.15%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
624.80K
2.2%
+323.43K
+107.32%
Jun 30, 2025
District 2 Capital LP
430.17K
1.51%
+7.77K
+1.84%
Jun 30, 2025
Bigger (Michael)
378.69K
1.33%
--
--
Jun 30, 2025
State Street Investment Management (US)
333.38K
1.17%
+207.53K
+164.91%
Jun 30, 2025
Brown Advisory
330.90K
1.16%
-191.00
-0.06%
Jun 30, 2025
Lane Generational, LLC
258.43K
0.91%
+16.38K
+6.77%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
Fidelity Digital Health ETF
1.58%
Invesco NASDAQ Future Gen 200 ETF
1.01%
iShares Neuroscience and Healthcare ETF
0.95%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
iShares Russell 2000 Growth ETF
0.04%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
查看更多
Fidelity Digital Health ETF
占比1.58%
Invesco NASDAQ Future Gen 200 ETF
占比1.01%
iShares Neuroscience and Healthcare ETF
占比0.95%
iShares Micro-Cap ETF
占比0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.09%
iShares Russell 2000 Growth ETF
占比0.04%
Motley Fool Next Index ETF
占比0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.03%
iShares Russell 2000 ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
